Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Smith, Amber
NCT04614662: Symptom Screening Linked to Care Pathways	Completed	3	445	Canada, US	SPARK Symptom Screening Linked to Feedback to Providers	The Hospital for Sick Children, National Cancer Institute (NCI)	Pediatric Cancer, Quality of Life	10/23	10/23
NCT00850317: Fanconi Anemia Transplant Lacking Genotypically Identical Donor	Not yet recruiting	2	25	US	Miltenyi CliniMACs device	Children's Hospital Boston, Dana-Farber Cancer Institute	Fanconi Anemia	04/12
VISTA, NCT06083753: Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects with Relapsing-Remitting Multiple Sclerosis	Active, not recruiting	2	168	US	PIPE-307 Dose A, PIPE-307 Dose B, Placebo	Contineum Therapeutics	Relapsing Remitting Multiple Sclerosis	08/25	09/25
Reese, Emily
VISTA, NCT06083753: Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects with Relapsing-Remitting Multiple Sclerosis	Active, not recruiting	2	168	US	PIPE-307 Dose A, PIPE-307 Dose B, Placebo	Contineum Therapeutics	Relapsing Remitting Multiple Sclerosis	08/25	09/25